|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Dr. Wu Investment Holding Representative: Eric Wu | Eric Wu | Tina Lin | (02)2517-9888 | 13F., No. 70, Sec. 3, Nanjing E. Rd., Zhongshan Dist.,Taipei City 104, Taiwan, R.O.C. | 2016/06/16 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | DR.WU is a line of highly effective skincare products developed with advanced patented technologies to target various problems in Asian skins. DR.WU developed base on such principles, which has No Additives, No Alcohol, High Concentration of High Grade Actives that are safe and effective, even for use on sensitive skins. With extensive experience, DR.WU’s ambition is to foot locally, to advance in Asia, and to think globally as the brand continues to set milestones in the medical skincare industry. |
Market Information ( 2023/06/02 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
126.498 | 126.50 | 125.00 | 126.50 | 1.00 | 152 | 985 | 4 | ||||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2023/06/02) |
TPEx measures adopted (2023/06/02) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | Y | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
![]() |
![]() |
![]() |